Cargando…
Computational Studies of a Mechanism for Binding and Drug Resistance in the Wild Type and Four Mutations of HIV-1 Protease with a GRL-0519 Inhibitor
Drug resistance of mutations in HIV-1 protease (PR) is the most severe challenge to the long-term efficacy of HIV-1 PR inhibitor in highly active antiretroviral therapy. To elucidate the molecular mechanism of drug resistance associated with mutations (D30N, I50V, I54M, and V82A) and inhibitor (GRL-...
Autores principales: | Hu, Guodong, Ma, Aijing, Dou, Xianghua, Zhao, Liling, Wang, Jihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926353/ https://www.ncbi.nlm.nih.gov/pubmed/27240358 http://dx.doi.org/10.3390/ijms17060819 |
Ejemplares similares
-
ERDRP-0519 inhibits feline coronavirus in vitro
por: Camero, Michele, et al.
Publicado: (2022) -
P05.19. Outcomes in breast cancer treatment decision-making
por: McKenzie, E, et al.
Publicado: (2012) -
In vitro metabolic characterization of the SARS-CoV-2 papain-like protease inhibitors GRL0617 and HY-17542
por: Cho, Hyunki, et al.
Publicado: (2023) -
GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants
por: Aoki, Manabu, et al.
Publicado: (2023) -
Antilisterial Bacteriocin from Lactobacillus rhamnosus CJNU 0519 Presenting a Narrow Antimicrobial Spectrum
por: Jeong, Ye-Jin, et al.
Publicado: (2015)